[Asia Economy Reporter Lee Jung-yoon]
▲Korea Zinc=Decision to provide a debt guarantee of KRW 315.48 billion to its affiliate Sun Metals Corporation
▲Samsung Biologics=Signed a pharmaceutical contract manufacturing agreement worth KRW 420.7 billion with GlaxoSmithKline Trading Service Limited
▲Hyundai Motor Securities=Preliminary operating profit for Q3 this year estimated at KRW 25.094 billion, down 38.0% compared to the same period last year
▲Lotte Holdings=Subsidiary Lotte Biologics decided on a KRW 240.5 billion rights offering
▲Kukdo Chemical=Preliminary operating profit for Q3 this year estimated at KRW 13.032 billion, down 77.0% compared to the same period last year
▲Lotte Chemical=Decision to lend KRW 500 billion to affiliate Lotte Construction
▲JW Pharmaceutical=Decision on rights offerings worth KRW 4.4 billion and KRW 5.6 billion for operating fund procurement
▲Daeyang Metal=Decision to issue the 22nd series of domestic bearer unsecured convertible bonds (CB) worth KRW 20 billion for the purpose of raising funds to acquire securities of other companies
▲T'way Air=Decision to provide collateral worth KRW 4.44752 billion to the T'way Air employee stock ownership association
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
